Koncen Overview
- Founded
- 2001
- Status
- Private
- Latest Deal Type
- Later Stage VC
- Investors
- 3
Koncen General Information
Description
Developer of medical technology intended to offer blood-purification. The company's technology helps to accelerate blood dialysis and blood purification adsorption, enabling healthcare providers to save the lives of the patients.
Contact Information
Website
www.koncen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Number 8, Shenzhou Street, Science City
- Luogang District
- Guangzhou, Luogang 510660
- China
+86 020 0000 0000
Koncen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 29-Mar-2018 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 01-Jan-2013 | Completed | Generating Revenue |
Koncen Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Xiaoyuan Chen | Koncen | Board Member | 000 0000 |
Koncen Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Hyfinity Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Sequoia Capital China | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Wen's Food Group | Corporation | Minority | 000 0000 | 000000 0 |